Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-26-000003

Options or other derivatives

  • Chief Commercial Officer acquired 50,030 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mottiwala Aziz · Chief Commercial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-05 Grant or award : show line 1 in the form Stock Option (right to buy) +30,724 30,724 D
2026-03-05 Grant or award : show line 2 in the form Restricted Stock Units +19,306 19,306 D
Loading xslF345X05/wk-form4_1773086801.xml…